Clinical Trial Update: Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on using allogeneic platelet lysate for peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Allogeneic platelet lysate

Snippet

Sponsor: Sophia Al-Adwan | Conditions: Peripheral Arterial Disease | Phase 1, Phase 2 | Status: UNKNOWN